News
MyChesCo on MSN11h
Aclaris Therapeutics Secures FDA Clearance for ATI-052 Clinical TrialWAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback